Production of recombinant woodchuck IFNα and development of monoclonal antibodies

Journal of Interferon and Cytokine Research

Volumn 29, Issue 2, 2009, Pages 75-81

  Berraondo, Pedro ^a   Crettaz, Julien ^a   Ochoa, Laura ^a   Vales, Africa ^a   Ruiz, Juan ^a   Prieto, Jesús ^a   Martinez Ansó, Eduardo ^a   González Aseguinolaza, Gloria ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN RWIFN ALPHA 5; RECOMBINANT ALPHA INTERFERON; STAT3 PROTEIN; UNCLASSIFIED DRUG; HEPATITIS B ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; IMMUNIZATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; WESTERN BLOTTING; WOODCHUCK; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MARMOTA; METABOLISM; MOLECULAR CLONING; PHOSPHORYLATION; RAT; TUMOR CELL LINE;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; HEPATITIS B; HEPATITIS B ANTIBODIES; INTERFERON-ALPHA; MARMOTA; PHOSPHORYLATION; RATS; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; MARMOTA MONAX; PROKARYOTA; RATTUS; WOODCHUCK HEPATITIS VIRUS;

EID: 59349106831     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0012     Document Type: Article

References (19)

1. Aurisicchio L, De Tomassi A, La Monica N, Ciliberto G, Traboni C, Palombo F. 2005. Regulated and liver-specific tamarin alpha interferon gene delivery by a helper-dependent adenoviral vector. J Virol 79(11):6772-6780.
2. Berraondo P, Garcia-Navarro R, Gonzalez-Aseguinolaza G, Vales A, Blanco-Urgoiti B, Larrea E, Riezu-Boj JI, Prieto J, Ruiz J. 2002. The woodchuck interferon-alpha system: Cloning, family description, and biologic activity. J Med Virol 68(3):424-432.
3. Berraondo P, Ochoa L, Crettaz J, Rotellar F, Vales A, Martinez-Anso E, Zaratiegui M, Ruiz J, Gonzalez-Aseguinolaza G, Prieto J. 2005. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes. Mol Ther 12(1):68-76.
4. Biron CA. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 10(5):383-390.
5. Caraglia M, Marra M, Pelaia G, Maselli R, Caputi M, Marsico SA, Abbruzzese A. 2005. Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202(2):323-335.
6. Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343(23):1666-1672.
7. Feitelson MA, Marion PL, Robinson WS. 1981. Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J Virol 39(2):447-454.
8. Fleischmann WR, Jr., Masoor J, Wu TY, Fleischmann CM. 1998. Orally administered IFN-alpha acts alone and in synergistic combination with intraperitoneally administered IFN-gamma to exert an antitumor effect against B16 melanoma in mice. J Interferon Cytokine Res 18(1):17-20.
9. Galibert F, Chen TN, Mandart E. 1982. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 41(1):51-65.
10. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258-267.
11. Kao JH, Chen DS. 2002. Global control of hepatitis B virus infection. Lancet Infect Dis 2(7):395-403.
12. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieto J. 1994. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 19(6):1400-1406.
13. Menne S, Cote PJ. 2007. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol 13(1):104-124.
14. Menne S, Tennant BC. 1999. Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks). Nat Med 5(10):1125-1126.
15. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H. 1999. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci USA 96(21):10818-10823.
16. Roggendorf M, Tolle TK. 1995. The woodchuck: an animal model for hepatitis B virus infection in man. Intervirology 38(1-2):100-112.
17. Roberts RM, Liu L, Guo Q, Leaman D, Bixby J. 1998. The evolution of the type I interferons. J Interferon Cytokine Res 18(10):805-816.
18. Yamagata Y, Iga K, Ogawa Y. 2000. Novel sustained-release dosage forms of proteins using polyglycerol esters of fatty acids. J Control Release 63(3):319-329.
19. Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. 2000. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343(23):1666-1672.